Evidence map›Paper›PMID 30983921›Full record

ArticleContrast media & molecular imaging2019

Erratum to "Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients".

Manuel Scimeca, Nicoletta Urbano, Rita Bonfiglio, Sarah Natalia Mapelli, Carlo Vittorio Catapano, Giuseppina Maria Carbone, Sara Ciuffa, Mario Tavolozza, Orazio Schillaci, Alessandro Mauriello and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Contrast media & molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Manuel ScimecaDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.ORCID 0000-0003-0585-1309
Nicoletta UrbanoNuclear Medicine, Policlinico "Tor Vergata", Rome, Italy.
Rita BonfiglioDepartment of Experimental Medicine and Surgery, University "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.ORCID 0000-0003-4172-2977
Sarah Natalia MapelliUniversità della Svizzera Italiana (USI), Institute of Oncology Research (IOR), Via Vela 6, Bellinzona, Switzerland.
Carlo Vittorio CatapanoUniversità della Svizzera Italiana (USI), Institute of Oncology Research (IOR), Via Vela 6, Bellinzona, Switzerland.
Giuseppina Maria CarboneUniversità della Svizzera Italiana (USI), Institute of Oncology Research (IOR), Via Vela 6, Bellinzona, Switzerland.
Sara CiuffaDepartment of Experimental Medicine and Surgery, University "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.
Mario TavolozzaNuclear Medicine, Policlinico "Tor Vergata", Rome, Italy.
Orazio SchillaciDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.
Alessandro MaurielloDepartment of Experimental Medicine and Surgery, University "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.ORCID 0000-0002-7351-5676
Elena BonannoDepartment of Experimental Medicine and Surgery, University "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.ORCID 0000-0002-0222-0141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1155/2018/9840962.].

Identifiers

PMID30983921
PMCPMC6432697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.